ASCENSIA DIABETES CARE NORWAY AS

1366 LYSAKER

Finances

Share Ownership

Return on Equity

8,52 %

Current Ratio

2,22

Debt-to-Equity Ratio

0,02

Key figures (NOK)	2023	2022	2021	2020
Revenue	97 176 000	96 075 000	99 622 000	128 909 000
Net Income	2 712 000	1 598 000	1 849 000	4 514 000
Total Assets	57 910 000	52 100 000	51 200 000	55 548 000
Total Equity	31 815 000	24 177 000	21 933 000	19 030 000

Income (NOK)	2023	2022	2021	2020
Revenue	97 176 000	96 075 000	99 622 000	128 909 000
Expenditure	93 478 000	93 868 000	97 104 000	122 975 000
Operating Profit	3 698 000	2 207 000	2 518 000	5 933 000
Financial Income	19 000	18 000	23 000	52 000
Financial Costs	215 000	154 000	130 000	124 000
Financial Balance	−196 000	−136 000	−107 000	−72 000
Earnings Before Tax	3 501 000	2 071 000	2 412 000	5 862 000
Tax	789 000	473 000	563 000	1 348 000
Net Income	2 712 000	1 598 000	1 849 000	4 514 000

Balance (NOK)	2023	2022	2021	2020
Total Fixed Assets	1 106 000	3 027 000	4 127 000	7 684 000
Total Current Assets	56 804 000	49 072 000	47 074 000	47 863 000
Total Assets	57 910 000	52 100 000	51 200 000	55 548 000
Total Retained Equity	17 565 000	9 928 000	7 684 000	4 781 000
Total Equity	31 815 000	24 177 000	21 933 000	19 030 000
Total Long-Term Debt	514 000	6 519 000	7 048 000	7 969 000
Total Current Debt	25 582 000	21 403 000	22 219 000	28 548 000
Total Equity and Debt	57 910 000	52 100 000	51 200 000	55 548 000

Cash flow (NOK)	2023	2022	2021	2020
Sales Income	97 176 000	96 075 000	98 122 000	128 684 000
Other Income	0	0	1 500 000	225 000
Revenue	97 176 000	96 075 000	99 622 000	128 909 000
Cost of Goods Sold	55 538 000	56 461 000	55 814 000	74 213 000
Salary Costs	21 335 000	22 779 000	22 590 000	23 825 000
Depreciation	556 000	724 000	3 742 000	4 747 000
Impairment	0	0	0	0
Expenditure	93 478 000	93 868 000	97 104 000	122 975 000
Operating Profit	3 698 000	2 207 000	2 518 000	5 933 000
Financial Income	19 000	18 000	23 000	52 000
Financial Costs	215 000	154 000	130 000	124 000
Financial Balance	−196 000	−136 000	−107 000	−72 000
Dividends	0	0	0	0
Net Income	2 712 000	1 598 000	1 849 000	4 514 000

Balance details (NOK)	2023	2022	2021	2020
Goodwill	0	505 000	1 177 000	4 867 000
Total Intangible Assets	716 000	2 807 000	3 855 000	7 361 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	168 000	220 000	272 000	324 000
Total Tangible Assets	168 000	220 000	272 000	324 000
Total Fiancial Fixed Assets	222 000	0	0	0
Total Fixed Assets	1 106 000	3 027 000	4 127 000	7 684 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	40 044 000	36 686 000	33 119 000	26 708 000
Total Current Assets	56 804 000	49 072 000	47 074 000	47 863 000
Total Assets	57 910 000	52 100 000	51 200 000	55 548 000
Total Equity	31 815 000	24 177 000	21 933 000	19 030 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	514 000	6 519 000	7 048 000	7 969 000
Creditors	15 110 000	8 412 000	7 624 000	13 292 000
Unpaid Taxes	3 945 000	6 187 000	5 953 000	7 694 000
Dividends	0	0	0	0
Other Current Debt	6 177 000	6 401 000	6 215 000	5 299 000
Total Current Debt	25 582 000	21 403 000	22 219 000	28 548 000
Total Equity and Debt	57 910 000	52 100 000	51 200 000	55 548 000

Financial indicators	2023	2022	2021	2020
Return on Equity	8,52 %	6,61 %	8,43 %	23,72 %
Debt-to-Equity Ratio	0,02	0,27	0,32	0,42
Operating Profit Margin	3,81 %	2,3 %	2,53 %	4,6 %
Current Ratio	2,22	2,29	2,12	1,68
Quick Ratio	2,22	2,29	2,12	1,68
Equity Ratio	0,55	0,46	0,43	0,34
Gross Profit Margin	42,85 %	41,23 %	43,97 %	42,43 %